» Articles » PMID: 8511595

Fibronectin, Cartilage, and Osteoarthritis

Overview
Specialty Rheumatology
Date 1993 Apr 1
PMID 8511595
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Fibronectin is a multifunctional glycoprotein present at low levels in the extracellular matrix of normal cartilage. In this tissue, as in others, it may be a component of a cell matrix adhesion complex together with cell-surface proteoglycans but also may play a role in the organization of the extracellular matrix. In osteoarthritis (OA), fibronectin content is markedly increased in the altered matrix because of an increased synthesis by the chondrocytes and accumulation in the extracellular matrix. At least part of the fibronectins synthesized in one degenerated cartilage is composed of isoforms more sensitive to proteolytic cleavage that are absent in normal cartilage. This increased content of fibronectin during osteoarthritic processes might entail several consequences related to the multiple functions of fibronectin and its generated fragments, namely a change in chondrocyte phenotype, a switch in synthesis of collagen type, an increased activity of locally secreted metalloproteases, and induction of self-proteolytic activities against gelatin and fibronectin. However, it is not yet clearly understood whether the early increased synthesis of fibronectin in OA acts as an "agent" in an attempt to repair cartilage by the chondrocytes or whether it acts as a deleterious "agent."

Citing Articles

A novel small molecule screening assay using normal human chondrocytes toward osteoarthritis drug discovery.

Coryell P, Hardy P, Chubinskaya S, Pearce K, Loeser R PLoS One. 2024; 19(11):e0308647.

PMID: 39485774 PMC: 11530018. DOI: 10.1371/journal.pone.0308647.


Development of bioactive solid-foam scaffolds from decellularized cartilage with chondrogenic and osteogenic properties.

Mendibil U, Lopiz-Morales Y, Arnaiz B, Ruiz-Hernandez R, Martin P, Di-Silvio D Mater Today Bio. 2024; 28:101228.

PMID: 39296356 PMC: 11408866. DOI: 10.1016/j.mtbio.2024.101228.


Integrin signalling in joint development, homeostasis and osteoarthritis.

Miao M, Lee J, Yamada K, Loeser R Nat Rev Rheumatol. 2024; 20(8):492-509.

PMID: 39014254 PMC: 11886400. DOI: 10.1038/s41584-024-01130-8.


Redox-active endosomes mediate α5β1 integrin signaling and promote chondrocyte matrix metalloproteinase production in osteoarthritis.

Miao M, Su Q, Cui Y, Bahnson E, Li G, Wang M Sci Signal. 2023; 16(809):eadf8299.

PMID: 37906629 PMC: 10666734. DOI: 10.1126/scisignal.adf8299.


Dysregulated integrin αVβ3 and CD47 signaling promotes joint inflammation, cartilage breakdown, and progression of osteoarthritis.

Wang Q, Onuma K, Liu C, Wong H, Bloom M, Elliott E JCI Insight. 2019; 4(18).

PMID: 31534047 PMC: 6795293. DOI: 10.1172/jci.insight.128616.